| Date | Form | Description | Docs | XBRL | Pages |
| 01/28/00 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
60 | |
| 03/31/99 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
13 | |
| 01/29/99 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
42 | |
| 01/29/98 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
40 | |
| 01/29/97 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
35 | |
| 01/29/96 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
44 |
- << Previous
- 1
- 2
- 3
- 4
- 5
Latest News & Events
Anixa Biosciences to Participate in Upcoming January Investor Conferences: LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect Conference
Read More...Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant
Read More...Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study
Read More...